Cosmos Health Inc (OQ:COSM)

Apr 19, 2024 04:30 pm ET
Cosmos Health Receives Nasdaq Notice on Late Filing of Its Form 10-K
CHICAGO, IL / ACCESSWIRE / April 19, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that, on April 17, 2024, it received a notification letter
Mar 21, 2024 09:45 am ET
Cosmos Health Commences Development of Cloudscreen 2.0, the New Iteration of its Next Generation AI Drug Repurposing Platform
CHICAGO, IL / ACCESSWIRE / March 21, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today the initiation of the development of Cloudscreen 2.0, the n
Mar 19, 2024 10:10 am ET
Cosmos Health To Receive Regulatory Approval for C-Scrub Disinfectant in the UK, Obtains Initial Purchase Order; Explores Opportunities Outside EU, Eyeing Global $36Bn+ Market
CHICAGO, IL / ACCESSWIRE / March 19, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today it is in the final stages of securing regulatory approval t
Mar 18, 2024 09:25 am ET
Cosmos Health Receives Regulatory Approval to Sell Sky Premium Life Products in $1.9Bn UAE Nutritional Supplements Market; Secures Initial Purchase Orders
CHICAGO, IL / ACCESSWIRE / March 18, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that it has received regulatory approval to sell its Sky Pr
Feb 29, 2024 09:25 am ET
Cosmos Health Successfully Completes Acquisition of Pharmatrade’s Assets; Expects to Increase FY 2024 Annual Revenue by over $5 Million
CHICAGO, IL / ACCESSWIRE / February 29, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today the successful acquisition of the distribution network o
Feb 21, 2024 11:50 am ET
Taglich Brothers Publishes First Coverage Report on Cosmos Health with a Price Target of $4, a Nearly Five-Fold Increase from Current Share Price
CHICAGO, IL / ACCESSWIRE / February 21, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that Taglich Brothers, Inc. ("Taglich Brothers"
Feb 21, 2024 09:30 am ET
Taglich Brothers Initiates Coverage of Cosmos Health Inc.
Taglich Brothers, Inc. announces that it has initiated coverage of Cosmos Health Inc. (NASDAQ: COSM). Cosmos Health Inc., headquartered in Chicago, Illinois is a diversified vertically integrated global health organization that manufactures and...
Feb 20, 2024 09:25 am ET
Cosmos Health CEO, Greg Siokas, Purchases Shares in the Open Market, Showcasing His Confidence in the Company
CHICAGO, IL / ACCESSWIRE / February 20, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that on February 16, 2024, its CEO, Mr. Greg Siokas, acq
Feb 01, 2024 09:25 am ET
Taglich Brothers Initiates Coverage of Cosmos Health Inc.
CHICAGO, IL / ACCESSWIRE / February 1, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that Taglich Brothers, Inc. ("Taglich Brothers"
Jan 23, 2024 01:05 pm ET
Cosmos Health Completes Acquisition of Cloudscreen, a Cutting-Edge AI Platform; Enters Lucrative $25Bn+ Global Drug Repurposing Market
CHICAGO, IL / ACCESSWIRE / January 23, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that it has successfully completed the acquisition of
Jan 18, 2024 09:25 am ET
Cosmos Health Bolsters Presence in $400Bn+ Global Generic Drugs Market with $3.5M Acquisition of 10-Drug Portfolio
CHICAGO, IL / ACCESSWIRE / January 18, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that it has successfully completed the acquisition of
Dec 27, 2023 09:27 am ET
Cosmos Health Set for Substantial Growth From Acquisitions Completed in 2023
CHICAGO, IL / ACCESSWIRE / December 27, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, today provided a business update highlighting the expected revenue growt
Dec 20, 2023 09:15 am ET
Cosmos Health Enters into Definitive Agreement to Acquire Type-2 Diabetes Treatment DIABIT-IS X
CHICAGO, IL / ACCESSWIRE / December 20, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that it has entered into a definitive agreement, subject
Dec 18, 2023 09:15 am ET
Cosmos Health Announces Open Market Stock Purchases by the CEO
CHICAGO, IL / ACCESSWIRE / December 18, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that its CEO, Mr Greg Siokas, intends to purchase an agg
Dec 08, 2023 12:45 pm ET
Cosmos Health to Participate at Capital Link’s 'Invest in Greece' Forum in New York
CHICAGO, IL / ACCESSWIRE / December 8, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, has announced the participation of its CEO, Greg Siokas, in
Dec 07, 2023 09:35 am ET
Cosmos Health Enters into Agreement to Acquire Rights for WIPO-Filed Patent on Drug Targeting CNS Cancers
According to Future Market Insights, the global brain tumor treatment market is expected to reach a value of $3.1 billion by the end of 2023 and is projected to grow at a compound annual growth rate (CAGR) of 7.2%, reaching a value of $6.2 billion by 2033. The increasing incidence of such cancers and the growing geriatric population are key factors expected to drive the growth of the brain tumor diagnosis market globally. During the historical period from 2018 to 2022, the market experienced a CAGR of 4.7%.
Dec 01, 2023 10:25 am ET
Cosmos Health Announces Patent Filing for its Obesity and Weight Management Product
CHICAGO, IL / ACCESSWIRE / December 1, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that it has filed a patent application with the European
Nov 21, 2023 09:00 am ET
Cosmos Health Reports Q3 2023 Results; Revenue Increased 7% YoY, Total Assets Reached Record $71.5M with Stockholders' Equity of $44.2M or $3.4/Share
THESSALONIKI, GREECE / ACCESSWIRE / November 21, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, today provided a business update and reported financial results
Oct 11, 2023 09:35 am ET
Cosmos Health to Acquire Cloudscreen, a Cutting-Edge AI-Powered Drug Repurposing Platform; Anticipated to Establish Cosmos as a Leader in the $25Bn Global Market and Deliver Unparalleled Returns for S
CHICAGO, IL / ACCESSWIRE / October 11, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that it has entered into a purchase agreement to acquire
Oct 05, 2023 08:30 am ET
COSMOS HEALTH CEO Issues Letter to Shareholders
CHICAGO, IL / ACCESSWIRE / October 5, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, today announces that its Chief Executive Officer, Greg Siokas, has issued
Sep 27, 2023 10:30 am ET
Cosmos Health Actively Exploring Spinoff of R&D Division into a Publicly Listed Standalone Biotech Company
CHICAGO, IL / ACCESSWIRE / September 27, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today its intention to spin off its research and development (R&D) division
Sep 26, 2023 11:00 am ET
Cosmos Health Announces Expansion of Its C-Sept Brand with the Launch of C-Scrub Wash; Capitalizing on $29 Billion Global Antiseptic and Disinfectant Market
CHICAGO, IL / ACCESSWIRE / September 26, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today the expansion of its C-Sept brand with the launch of the new C-Scrub Wash
Sep 21, 2023 05:00 pm ET
Cosmos Health Announces Relaunch of bio-bebe(R), its Proprietary Organic Infant Care & Nutrition Brand; Aims to Penetrate $103bn Global Baby Food Market
CHICAGO, IL / ACCESSWIRE / September 22, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today the relaunch of its organic infant care and nutrition brand, bio-bebe®
Sep 20, 2023 11:50 am ET
Cosmos Health Announces Strategic Collaboration with C.A.PAPAELLINAS Group
CHICAGO, IL / ACCESSWIRE / September 20, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that it has entered into a strategic collaboration with C.A.PAPAELLINAS Gr
Sep 13, 2023 08:30 am ET
Cosmos Health Starts Stock Buyback Program
CHICAGO, IL / ACCESSWIRE / September 13, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today the start of the Company's stock buyback program.
Sep 12, 2023 08:30 am ET
Cosmos Health Introduces Guidance; Expects to Achieve Over $180M in Gross Annual Revenue and EBITDA in Excess of $20M by 2026; Recaps Significant Events Reported So Far in 2023
CHICAGO, IL / ACCESSWIRE / September 12, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, today announced its inaugural 2026 revenue and EBITDA guidance and released a recap of the Company's significant activities and events report
Aug 15, 2023 07:00 am ET
Cosmos Health Reports Q2 2023 Financial Results; Adjusted Net Income Increases by 3550% to Surpass $3 Million for H1 2023 vs $(0.09) Million H1 2022; Book Value per Share Exceeds $4.04
CHICAGO, IL / ACCESSWIRE / August 15, 2023 / Cosmos Health Inc. ("Cosmos Health" or "the Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, today reported its financial results for the second quarter of 2023.
Aug 08, 2023 09:20 am ET
Cosmos Health Appoints Big 4 Accounting Firm KPMG as Auditor
CHICAGO, IL / ACCESSWIRE / August 8, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, announced today the engagement of KPMG Certified Auditors S.A. ("KPMG") as the Company's independent registered public accounting firm, effective August 7, 2023. KPMG replaces the Company's former auditor
Aug 02, 2023 01:15 pm ET
Cosmos Health Continues to Expand Mediterranation Brand, Welcomes Eleonas and Olympus Mons; Boosts Exports and Secures Purchase Orders, Including from Leading Multinational Health Food Chain
CHICAGO, IL / ACCESSWIRE / August 2, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, announced today the launch of Eleonas and Olympus Mons, the latest additions to its Mediterranation line of products, and is in the process of ramping up its export growth and sales, after having secured several pu
Jul 25, 2023 09:25 am ET
Cosmos Health Provides Update on Recent Developments, Maintains Strong Financial Position, Reaffirms Commitment to Growth, and Highlights CEO's Continued Investment Now Exceeds $15 Million
CHICAGO, IL / ACCESSWIRE / July 25, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today provided an update on recent developments, reaffirming the management team's belief and commitment to future prospects, and highlighting CEO Greg Siokas' participation in all capital raises since inception.
Jul 21, 2023 04:00 pm ET
Cosmos Health Inc. Announces Closing of $5.25 Million Registered Direct Offering and Concurrent Private Placement
CHICAGO, IL / ACCESSWIRE / July 21, 2023 / Cosmos Health Inc. (the "Company") (Nasdaq:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today announced the closing of its previously announced offering of 2,116,936 shares of the Company's common stock (or common stock equivalents in lieu thereof) in a regist
Jul 20, 2023 08:00 am ET
Cosmos Health Inc. Announces Pricing of $5.25 Million Registered Direct Offering and Concurrent Private Placement
CHICAGO, IL / ACCESSWIRE / July 20, 2023 / Cosmos Health Inc. (the "Company") (NASDAQ:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today announced that it has entered into securities purchase agreements with institutional investors for the purchase and sale of 2,116,936 shares of the Company's common s
Jul 06, 2023 09:20 am ET
Cosmos Health Successfully Completes Acquisition of Cana Laboratories; Anticipates to Record a Substantial Gain on Bargain Purchase
CHICAGO, IL / ACCESSWIRE / July 6, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, announced today the successful closing of the acquisition of Pharmaceutical Laboratories CANA S.A., ("Cana"), a Greek pharmaceutical company that manufactures, s
Jun 29, 2023 09:30 am ET
Cosmos Health Launches Chios Island, the Latest Addition to Its Mediterranation Premium Line of Supplements
CHICAGO, IL / ACCESSWIRE / June 29, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, announced today the launch of Chios Island, the latest addition to the Mediterranation line of products.
Jun 21, 2023 09:20 am ET
Cosmos Health Successfully Completes Second Phase of CCX0722 Development, an Innovative Product for Obesity and Weight Management: Significant Step in Bringing Product to the Multi-Billion-Dollar Mark
CHICAGO, IL / ACCESSWIRE / June 21, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, announced today the successful completion of the second phase in the development of the CCX0722 product and its extensions, an innovative solution for obesity and weight management.
Jun 16, 2023 09:15 am ET
Cosmos Health Successfully Closes Acquisition of Assets from I. Bikas GP; Annual Revenue Projected to Grow by over $10 Million
CHICAGO, IL / ACCESSWIRE / June 16, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, announced today the successful closing of the acquisition of the distribution network owned by I.Bikas General Partnership ("Bikas"), an established pharmaceutical company that has been operating in Gr
Jun 13, 2023 12:00 pm ET
Cosmos Health Expands Premium Nutritional Supplements Line Mediterranation with the Launch of Terra Creta
CHICAGO, IL / ACCESSWIRE / June 13, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, announced today the launch of Terra Creta, the latest addition to the Mediterranation line of products.
May 31, 2023 09:15 am ET
Cosmos Health set to join Russell Microcap Index
CHICAGO, IL / ACCESSWIRE / May 31, 2023 / Cosmos Health Inc. ("Cosmos Health" or "the Company") (NASDAQ:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, announced today that it is set to join the Russell Microcap® Index at the conclusion of the 2023 Russell indexes annual reconstitution, effective after the US market opens on June 26, according to
May 25, 2023 11:00 am ET
Cosmos Health Enters into Binding Letter of Intent for the Acquisition of Docpharm GmbH., an Established German Pharmaceutical Distributor; Expected to Boost Our Annual Revenue by Approximately €32M,
CHICAGO, IL / ACCESSWIRE / May 25, 2023 / Cosmos Health Inc. ("Cosmos Health" or "the Company") (NASDAQ:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, announced today that it has executed a binding Letter of Intent (LOI) to acquire all of the outstanding shares of Docpharm GmbH. ("Docpharm"), an established pharmaceutical distributor based in Germany.
May 17, 2023 08:00 am ET
Cosmos Health Reports First Quarter 2023 Financial Results; Delivers Positive Adjusted EBITDA and Significant Increase in Adjusted Net Income
CHICAGO, IL / ACCESSWIRE / May 17, 2023 / Cosmos Health Inc. ("Cosmos Health" or "the Company") (NASDAQ:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today provided a business update and reported financial results for the first quarter ended March 31, 2023.
May 08, 2023 11:45 am ET
Cosmos Health Enters Final Phase for the Acquisition of Cana Laboratories Following Conclusion of Stock Purchase Agreement
CHICAGO, IL / ACCESSWIRE / May 8, 2023 / Cosmos Health Inc. ("Cosmos Health" or "the Company") (NASDAQ:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, announced today that it has executed a Stock Purchase Agreement ("SPA") for, and has now entered the final phase for the acquisition of, Pharmaceutical Laboratories C
May 03, 2023 01:35 pm ET
Cosmos Health Advances Its Strategic Plan; Acquires Distressed Property Housing Operations of CosmoFarm, Expected to Generate Substantial Value for Shareholders
CHICAGO, IL / ACCESSWIRE / May 3, 2023 / Cosmos Health Inc. ("Cosmos Health" or "the Company") (NASDAQ:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today announced that is has acquired the entire property which houses the operations of its wholly owned subsidiary CosmoFarm Pharmaceuticals ("CosmoFarm"), a ful
Apr 13, 2023 07:00 am ET
Cosmos Health Ends 2022 with Transformed Balance Sheet and Achieves Positive Adjusted EBITDA for the Fiscal Year 2022
CHICAGO, IL / ACCESSWIRE / April 13, 2023 / Cosmos Health Inc. ("Cosmos Health" or "the Company") (NASDAQ:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today provided a business update and reported financial results for the fiscal year ended December 31, 2022.
Apr 05, 2023 09:50 am ET
Cosmos Health Inc. to Participate in The Economist Annual New York-Eastern Mediterranean Business Summit on July 10th, 2023, with CEO Mr. Greg Siokas Delivering a Speech
CHICAGO, IL / ACCESSWIRE / April 5, 2023 / Cosmos Health Inc. ("Cosmos Health" or "the Company") (Nasdaq:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, announced today that it will participate in The Economist Annual New York-Eastern Mediterranean Business Summit entitled "A New Momentum for Geopolitics and Investme
Apr 03, 2023 11:55 am ET
Cosmos Health Inc. Enters U.S. Telehealth Space with Successful Acquisition of ZipDoctor, Inc.
CHICAGO, IL / ACCESSWIRE / April 3, 2023 / Cosmos Health Inc. ("Cosmos Health" or "the Company") (Nasdaq:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, announced today that it has successfully completed the acquisition of ZipDoctor, Inc. ("ZipDoctor") from American International Holdings Corp (AMIH). The financial terms of the acquisition were not dis
Mar 24, 2023 10:35 am ET
Cosmos Health Inc.'s UK Subsidiary Decahedron Ltd. Named Pharmaceutical Wholesaler of the Month in the Latest Issue of Healthcare Matters
CHICAGO, IL / ACCESSWIRE / March 24, 2023 / Cosmos Health Inc. ("Cosmos Health" or "the Company") (Nasdaq:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, announced today that its subsidiary in the United Kingdom, Decahedron Ltd., has been named "Pharmaceutical Wholesaler of the Month" in the Mar/Apr 2023 issue of He
Mar 17, 2023 01:45 pm ET
Cosmos Health Inc. Enters into a Definitive Agreement to Acquire ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp.
CHICAGO, IL / ACCESSWIRE / March 17, 2023 / Cosmos Health Inc. ("Cosmos Health" or "the Company") (Nasdaq:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, announced today that it has entered into a definitive agreement to acquire ZipDoctor Inc. from American International Holdings Corp (AMIH) for an undisclosed sum. The Sale and Purchase Agreement ("SPA"
Mar 07, 2023 09:15 am ET
Cosmos Health Enters into a Material Definitive Agreement with Cana Laboratories
CHICAGO, IL / ACCESSWIRE / March 7, 2023 / Cosmos Health Inc. ("Cosmos Health" or "the Company") (Nasdaq:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, announced today that it has entered into a material definitive agreement with Pharmaceutical Laboratories CANA S.A., ("Cana") a Greek pharmaceutical company tha
Mar 03, 2023 08:25 am ET
Cosmos Health Expects to Acquire ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp.
CHICAGO, IL / ACCESSWIRE / March 3, 2023 / Cosmos Health Inc. ("the Company") (Nasdaq:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, announced today that it has concluded its due diligence and is in the process of preparing the definitive documentation to complete the acquisition of ZipDoctor Inc. from American International Holdings Corp (AMIH).
Feb 15, 2023 03:30 pm ET
Cosmos Health Extends its Agreement to Acquire ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp.
CHICAGO, IL / ACCESSWIRE / February 15, 2023 / Cosmos Health, Inc. ("the Company") (Nasdaq:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, announced today that it has extended its previously issued non-binding letter of intent (LOI) to acquire ZipDoctor Inc. from American International Ho
Feb 07, 2023 09:15 am ET
Cosmos Health Announces Initial Purchase Order with Virax Biolabs for the Distribution of COVID-19 and Influenza A+B Antigen Combo Rapid Tests
CHICAGO, IL / ACCESSWIRE / February 7, 2023 / Cosmos Health Inc. ("the Company") (NASDAQ:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, is pleased to announce the first purchase order to market and distribute Virax Biolabs' (Nasdaq: VRAX) ViraxClear branded COVID-19 and Influenza A+B Antigen Combo Rapid
Feb 07, 2023 07:30 am ET
Virax Biolabs Group Limited Announces Purchase Order to Launch COVID-19 and Influenza A+B Antigen Combo Rapid Tests with Cosmos Health (NASDAQ:COSM)
LONDON, Feb. 7, 2023 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative diagnostics company focused on the prevention, detection, and diagnosis of viral diseases, announced that it has signed a Purchase Order with Cosmos Health (Nasdaq: COSM) ("Cosmos") to launch and market COVID-19 and Influenza A+B Antigen Combo Rapid Detection Kits. Pursuant to their previously signed distribution agreement dated September 2022, Cosmos will have exclusive distribution rights for Greece and Cyprus, with the opportunity to distribute the ViraxClear branded t
Feb 02, 2023 01:50 pm ET
Cosmos Health Announces Application for Dual Listing on Upstream
CHICAGO, IL / ACCESSWIRE / February 2, 2023 / Cosmos Health Inc. (Nasdaq:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today announced that is has begun the application process to dual list its shares on Upstream, the trading app for digital securities and NFTs powered by Horizon Fintex ("Horizon") and
Feb 01, 2023 11:00 am ET
Cosmos Health Announces the Appointment of Nikos Bardakis, an Experienced Executive in the Pharmaceutical Industry, as Chief Operating Officer
CHICAGO, IL / ACCESSWIRE / February 1, 2023 / Cosmos Health Inc. ("the Company") (Nasdaq:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, is pleased to announce the appointment of Nikos Bardakis, who comes with over two decades of international branded pharmaceutical sector experience, as the Chief Operati
Jan 26, 2023 03:00 pm ET
Cosmos Health Retains Christian Levine Law Group to Further Monitor Trading Irregularities
CHICAGO, IL / ACCESSWIRE / January 26, 2023 / Cosmos Health, Inc. ("the Company") (Nasdaq:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, announces that in response to the data obtained through Shareholder Intelligence Services, it has retained services of Wes Christian of Christian Levine Law Group and A
Jan 24, 2023 12:40 pm ET
Cosmos Health Announces Stock Buyback Program
CHICAGO, IL / ACCESSWIRE / January 24, 2023 / Cosmos Health, Inc. ("the Company") (Nasdaq:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today announced that its Board of Directors has approved a share repurchase program with authorization to purchase up to $3 million of its common stock.
Jan 20, 2023 01:40 pm ET
Jan 17, 2023 09:15 am ET
Cosmos Health Provides an Update on its Debt Balance and Proforma Interest Expense
Reduced its debt by 78% from $21.2M in 2021 to $4.6M in 2022 and expects interest expense in 2023 to be $0.6M versus $2.2M in 2022.
Jan 10, 2023 11:55 am ET
Cosmos Health Extends and Updates its Agreement to Acquire Cana Laboratories, a European Pharmaceutical Company
Vertically Integrating its Manufacturing and R&D Capabilities and Expanding its Product Pipeline with New Brands
Jan 05, 2023 09:05 am ET
Cosmos Health Regains Nasdaq Minimum Bid Price Compliance
COSM Will Continue to Trade on Nasdaq Without Any Disruption
Dec 28, 2022 09:57 am ET
Thinking about buying stock in Minerva Surgical, IQIYI, Cosmos Health, Acasti Pharma, or AMC Entertainment?
NEW YORK, Dec. 28, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for UTRS, IQ, COSM, ACST, and AMC.
Dec 22, 2022 11:40 am ET
Cosmos Health CEO Participated in the Last Fundraising of the Company
Re-affirming His Commitment to Growth and Profitability
Dec 21, 2022 04:10 pm ET
Cosmos Health Inc. Announces Successful Closing of $32.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market
CHICAGO, IL / ACCESSWIRE / December 21, 2022 / Cosmos Health Inc. (the "Company") (NASDAQ:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today announced the closing of its previously announced registered direct offering
Dec 19, 2022 10:02 am ET
Thinking about buying stock in SINTX Technologies, Cosmos, Core Scientific, TAL Education, or Axcella Health?
NEW YORK, Dec. 19, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SINT, COSM, CORZ, TAL, and AXLA.
Dec 19, 2022 09:12 am ET
Cosmos Health Inc. Announces Pricing of $32.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market
CHICAGO, IL / ACCESSWIRE / December 19, 2022 / Cosmos Health Inc. (the "Company") (Nasdaq:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today announced that it has entered into securities purchase agreements with institutional investors for the purchase and sale of 2,82
Dec 16, 2022 09:34 am ET
Thinking about buying stock in Cosmos, Mullen Automotive, Amazon, Intel, or AT&T?
NEW YORK, Dec. 16, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for COSM, MULN, AMZN, INTC, and T.
Dec 15, 2022 07:45 am ET
Cosmos Holdings Inc. Changes its Name to Cosmos Health Inc. and Announces a 1-For-25 Reverse Stock Split
CHICAGO, IL / ACCESSWIRE / December 16, 2022 / Cosmos Holdings Inc. d/b/a Cosmos Health ("the Company") (Nasdaq:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, announced a reverse stock split with a ratio of 1-for-25 (one-for-twenty five) effective at the opening of the business day on Friday, December 16
Dec 09, 2022 11:30 am ET
Cosmos Health Retains Shareholder Intelligence Services, LLC
CHICAGO, IL / ACCESSWIRE / December 9, 2022 / Cosmos Holdings d/b/a Cosmos Health, Inc. ("the Company") (NASDAQ:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, announced that it has retained Shareholder Intelligence Services, LLC ("ShareIntel"), to review the trading patterns of the Company's co
Dec 05, 2022 09:56 am ET
Thinking about buying stock in Tilray, Cosmos, IQIYI, Credit Suisse, or EHang?
NEW YORK, Dec. 5, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TLRY, COSM, IQ, CS, and EH.
Dec 02, 2022 03:10 pm ET
Cosmos Health Provides a Summary Regarding Recent Share Activity and Reiterates its Belief and Commitment to the Financial Strength and the Growth and Profitability of the Company
CHICAGO, IL / ACCESSWIRE / December 2, 2022 / Cosmos Holdings d/b/a Cosmos Health, Inc. ("the Company") (Nasdaq:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, provided a summary regarding recent share activity, including the participation of CEO, Greg Siokas on all capital raises. Management reiterates i
Dec 02, 2022 09:44 am ET
Thinking about buying stock in TOP Ships, Nio, Cosmos Holdings, AMC Entertainment, or Canopy Growth Corp?
NEW YORK, Dec. 2, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TOPS, NIO, COSM, AMC, and CGC.
Dec 01, 2022 12:10 pm ET
Thinking about buying stock in Mullen Automotive, Cosmos, TOP Ships, Xpeng, or Farfetch?
NEW YORK, Dec. 1, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MULN, COSM, TOPS, XPEV, and FTCH.
Nov 30, 2022 09:46 am ET
Thinking about buying stock in Xpeng, Nike, Futu, Li Auto, or Cosmos Holdings?
NEW YORK, Nov. 30, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for XPEV, NKE, FUTU, LI, and COSM.
Nov 29, 2022 05:10 pm ET
Cosmos Health Enters the Development Phase for CCX0722, an Innovative Product for Obesity and Weight Management
CHICAGO, IL / ACCESSWIRE / November 29, 2022 / Cosmos Holdings d/b/a Cosmos Health, Inc. ("the Company") (NASDAQ:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today announced that it has entered the development phase for CCX0722, an innovative product for obesity and weight management, based on the effe
Nov 29, 2022 07:34 am ET
Thinking about buying stock in Apollo Endosurgery, OncoSec Medical, Cosmos Holdings, Zhihu, or Bilibili?
NEW YORK, Nov. 29, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for APEN, ONCS, COSM, ZH, and BILI.
Nov 28, 2022 07:30 am ET
Thinking about buying stock in Univar Solutions, Cosmos Holdings, Taboola.com, Shopify, or Melco Resorts & Entertainment?
NEW YORK, Nov. 28, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for UNVR, COSM, TBLA, SHOP, and MLCO.
Nov 25, 2022 09:39 am ET
Thinking about buying stock in Cosmos Holdings, Coupa Software, VEON, Johnson & Johnson, or HP?
NEW YORK, Nov. 25, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for COSM, COUP, VEON, JNJ, and HPQ.
Nov 23, 2022 07:30 am ET
Thinking about buying stock in Carvana, Cosmos Holdings, Porch Group, NeuroOne Medical Technologies, or Manchester United?
NEW YORK, Nov. 23, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CVNA, COSM, PRCH, NMTC, and MANU.
Nov 22, 2022 09:44 am ET
Thinking about buying stock in Obseva SA, Cosmos Holdings, Alibaba, American Eagle Outfitters, or TJX Companies?
NEW YORK, Nov. 22, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for OBSV, COSM, BABA, AEO, and TJX.
Nov 21, 2022 07:00 am ET
Cosmos Health to Sell its Sky Premium Life Luxury Food Supplement Brand on Iberian Airlines' In-flight Magazine, Ronda.
CHICAGO, IL / ACCESSWIRE / November 21, 2022 / Cosmos Holdings d/b/a Cosmos Health, Inc. ("the Company") (Nasdaq:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today announced that its Sky Premium Life luxury food supplement brand will be sold on Ronda, the official inflight magazine of the airline compa
Nov 17, 2022 01:15 pm ET
Cosmos Health Requests Appeal from the Nasdaq Stock Market
Stock will continue to trade on Nasdaq beyond November 21, 2022
Nov 15, 2022 11:05 am ET
Cosmos Health Reports Third Quarter 2022 Financial Results
CHICAGO, IL / ACCESSWIRE / November 15, 2022 / Cosmos Holdings (d/b/a Cosmos Health, Inc.) ("the Company") (Nasdaq:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today provided a business update and reported financial results for the third quarter and nine months ended September 30, 2022.
Nov 14, 2022 09:00 am ET
Cosmos Health Obtains Exclusive Rights to Market and Distribute Nickelodeon's SpongeBob and PAW Patrol Kids' Vitamins in Greece and Cyprus
CHICAGO, IL / ACCESSWIRE / November 14, 2022 / Cosmos Holdings d/b/a Cosmos Health, Inc. ("the Company") (NASDAQ:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today announced an exclusive agreement to market and distribute Nickelodeon's SpongeBob and PAW Patrol kids' vitamins in Greece and Cyprus. Nicke
Oct 27, 2022 09:50 am ET
Cosmos Health and Smart for Life Execute Letter of Intent for Strategic Global Co-Venture
Cosmos Holdings d/b/a Cosmos Health, Inc. (“Cosmos") (Nasdaq: COSM) and Smart for Life, Inc. (Nasdaq: SMFL), both high growth leaders in the Health & Wellness sector marketing and manufacturing nutritional foods and supplements today announced that...
Oct 18, 2022 08:00 am ET
Cosmos Health Announces Pricing of $7.5 Million Upsized Public Offering
CHICAGO, IL / ACCESSWIRE / October 18, 2022 / Cosmos Holdings (d/b/a Cosmos Health, Inc.) ("Cosmos" or the "Company") (NASDAQ:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today announced the pricing of its "reasonable best efforts" public offering of 62,500,000 shares of common stock (or common stock equivalents), Series A Warrants to purchase 62,500,000 shares of common stock and Series B Warrant to purchase 62,500,000 shares of
Oct 04, 2022 09:00 am ET
Sep 28, 2022 09:00 am ET
Cosmos Health Enters into Letter of Intent for the Acquisition of ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp.
CHICAGO, IL / ACCESSWIRE / September 28, 2022 / Cosmos Holdings d/b/a Cosmos Health, Inc. ("Cosmos") (NASDAQ:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today announced that it has entered into a non-binding letter of intent (LOI) agreement to wholly acquire ZipDoctor Inc. from American International
Sep 22, 2022 09:20 am ET
Cosmos Health Signs an Agreement with Virax Biolabs to Distribute Monkeypox Virus Real-Time PCR Detections Kits in Europe
CHICAGO, IL / ACCESSWIRE / September 22, 2022 / Cosmos Holdings d/b/a Cosmos Health, Inc. ("Cosmos") (NASDAQ:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today announced that it has entered into an agreement with Virax Biolabs (VRAX), to become the distributor of Monkeypox Virus Real-Time PCR Detection
Sep 22, 2022 07:30 am ET
Virax Biolabs Group Limited Announces Distribution Agreement to Market Monkeypox Virus Real-Time PCR Detection Kit with Cosmos Holdings Inc.
Exclusive distribution agreement signed with Cosmos Holdings Inc. (Nasdaq: COSM), providing for exclusive distribution rights in Greece and Cyrus with the opportunity for Cosmos to distribute across Europe on a non-exclusive basis.LONDON, Sept. 22, 2022 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative diagnostics company focused on the prevention, detection, and diagnosis of viral diseases, announced today that it has entered into a distribution agreement to market Monkeypox Virus Real-Time PCR Detection Kits with Cosmos Holdings Inc. (Nasd
Sep 15, 2022 09:15 am ET
Cosmos Health to Launch Sky Premium Life Nutritional Supplement Products in Germany and Austria via Amazon and Ebay
CHICAGO, IL / ACCESSWIRE / September 15, 2022 / Cosmos Holdings d/b/a Cosmos Health, Inc. ("the Company") (Nasdaq:COSM), is a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today announced that the Company's proprietary line of nutraceuticals, Sky Premium Life, has entered into an exclusive agreement with Medipro
Aug 25, 2022 09:25 am ET
Cosmos Health Launches First Sky Premium Life Nutritional Supplement Products on Amazon in the United States
CHICAGO, IL / ACCESSWIRE / August 25, 2022 / Cosmos Holdings d/b/a Cosmos Health, Inc. ("the Company") (NASDAQ:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today announced that the Company's subsidiary, SkyPharm S.A., a pharmaceutical wholesaler and distributor, officially launched its first Sky Premiu
Aug 22, 2022 09:15 am ET
Cosmos Health Reports 202.42 % Increase in Adjusted EBITDA and Positive Operating Income for the First Half of 2022
CHICAGO, IL / ACCESSWIRE / August 22, 2022 / Cosmos Health, Inc. ("the Company") (NASDAQ:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices,today provided a business update and reported financial results for the second quarter and six months ended June 30, 2022.
Jul 29, 2022 09:15 am ET
Cosmos Holdings Announces Name Change to Cosmos Health, Reflecting Company's Evolution into an Innovative Global Healthcare Group, Driven by One Purpose: Improving People's Lives
CHICAGO, IL / ACCESSWIRE / July 29, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM) announced today that it is changing the name of the Company to Cosmos Healthto better reflect the Company's evolution into an innovative global healthcare group with a focus on improving people's lives. The enhancement with cutting edge technlogies for the development of its pharmaceutical and nutraceutical products, through i
Jul 22, 2022 09:15 am ET
Cosmos Holdings Appoints Dr. Manfred Ziegler to its Advisory Board
CHICAGO, IL / ACCESSWIRE / July 22 , 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices, today announced that it has appointed finance veteran Dr. Manfred Ziegler to the Company's Advisory Board.
Jul 20, 2022 09:15 am ET
Cosmos Holdings Announces Agreement to Acquire Cana Laboratories, a Legacy European Pharmaceutical Company Established in 1928; Vertically Integrating its Manufacturing and R&D Capabilities and Expand
CHICAGO, IL / ACCESSWIRE / July 20, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices, today announced that it has entered into a binding letter of intent to acquire Pharmaceutic
Jul 12, 2022 09:15 am ET
Cosmos Holdings Subsidiary Granted Full Membership in PAGB, A UK-based Consumer Healthcare Association
Products will be listed on PAGB's OTC Directory online, a go-to resource for healthcare professionals
Jul 08, 2022 09:15 am ET
Cosmos Holdings Appoints Dr. Panagiotis Zoumpoulakis to its Advisory Board
CHICAGO, IL / ACCESSWIRE / July 8, 2022 / Cosmos Holdings, Inc. ("the Company") (Nasdaq:COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices, today announced the appointment of Panagiotis Zoumpoulakis, Ph.D., MBA, to its Advisory Board.
Jul 06, 2022 09:15 am ET
Cosmos Holdings to Acquire LIFE NLB Portfolio of Bone Health Products that Target the Gastrointestinal Microbiome
Acquisition will include all launched and under development bone health products
Jun 30, 2022 08:30 am ET
Cosmos Holdings Announces Strategic R&D Partnership with Cloudpharm P.C. to Study the Human Gastrointestinal Microbiome and Launch Related Products Targeting on Obesity and Other Gut-Related Disorders
CHICAGO, IL / ACCESSWIRE / June 30, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices, today announced a strategic partnership with Cloudpharm P.C., a bio-pharmaceutical R&D company focused on the discovery of bioactive
Jun 02, 2022 09:00 am ET
Cosmos Holdings to Launch Sky Premium Life Nutritional Supplements on Amazon in the United States
First commercial launch of the Company's nutraceutical products in the U.S. follows successful launches on Amazon in other key markets
May 24, 2022 07:00 am ET
CEO Presenting on the Emerging Growth Conference on May 25 Register Now
EmergingGrowth.com a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth Companies and Markets announces the Schedule of the 31st Emerging Growth Conference. The Emerging...
May 18, 2022 08:30 am ET
Cosmos Holdings Reports 12.5% Increase in Revenue, 88.9% Increase in Gross Profit and Achieves Profitability for the First Quarter of 2022
Reports Positive Net Income of $0.2 Million and $1.2 Million of EBITDA for the First Quarter of 2022
May 05, 2022 09:15 am ET
Cosmos Holdings to Launch Sky Premium Life Nutritional Supplements on Amazon Canada
First commercial launch of nutraceutical products in North American Market
May 03, 2022 09:15 am ET
Cosmos Holdings Appoints Finance Veteran Dr. Anastasios Aslidis to the Board of Directors and as a Member of the Board's Audit Committee
CHICAGO, IL / ACCESSWIRE / May 3, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices, today announced it has appointed finance veteran Dr. Anastasios Aslidis to the Board of Directors and as a member of the Board's audit com
Apr 19, 2022 09:15 am ET
Cosmos Holdings Reports Continued Revenue Growth and Achieves $3.3 Million of Adjusted EBITDA for the Fiscal Year 2021
CHICAGO, IL / ACCESSWIRE / April 19, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices, today provided a business update and reported financial results for the year ended December 31, 2021.
Apr 12, 2022 09:15 am ET
Cosmos Holdings Launches Mediterranation, a New Premium Nutritional Supplements Line
New line contains unique formulations and ingredients found in specific regions in Greece and the Mediterranean
Apr 05, 2022 09:15 am ET
Cosmos Holdings to Launch Sky Premium Life Nutritional Supplements on Amazon Singapore
CHICAGO, IL / ACCESSWIRE / April 5, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices, today announced that the Company's subsidiary, SkyPharm S.A., a pharmaceutical wholesaler and distributor, is launching Sky Premium Life
Mar 31, 2022 09:00 am ET
Mar 28, 2022 09:00 am ET
Cosmos Holdings Launches Proprietary Sky Premium Life Prostatium Supplement for Prostate Health
Designed to prevent and protect against Benign Prostate Hyperplasia, which affects millions of men worldwide
Mar 24, 2022 09:00 am ET
Cosmos Holdings to Present at the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest
CHICAGO, IL / ACCESSWIRE / March 24, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices, announced today that it will be presenting at the Virtual Growth Conference, presented by Maxim Group LLC and hosted by M-Vest, on Marc
Mar 23, 2022 09:25 am ET
Cosmos Holdings CEO Provides Letter to Shareholders
CHICAGO, IL / ACCESSWIRE / March 23, 2022 / Cosmos Holdings, Inc. ("the Company") (Nasdaq:COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices, provides the following letter to its shareholders from CEO Greg Siokas:
Mar 11, 2022 08:30 am ET
Cosmos Holdings to Ring Closing Bell Today to Celebrate Milestone NASDAQ Listing
CHICAGO, IL / ACCESSWIRE / March 11, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices, announced today it will celebrate its recent listing on the Nasdaq Stock Market by ringing the Nasdaq Closing Bell in Times Square, New
Feb 28, 2022 05:00 pm ET
Cosmos Holdings Announces Closing of $6 Million Private Placement of Convertible Preferred Stock and Start of Trading on the Nasdaq
Cosmos Holdings, Inc. (“the Company") (Nasdaq: COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices,...
Feb 28, 2022 08:30 am ET
Cosmos Holdings Announces $6 Million Private Placement of Convertible Preferred Stock and Approval to List on the Nasdaq
Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices,...
Dec 20, 2021 12:40 pm ET
Cosmos Holdings Announces Shareholder Approval of Private Offering
Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices,...
Nov 16, 2021 09:15 am ET
Cosmos Holdings Achieves Positive Adjusted Net Income and Positive Adjusted EBITDA for the Third Quarter of 2021
Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices,...
Nov 15, 2021 09:11 am ET
Cosmos Holdings Announces Installation of State-of-the-Art Automated Fulfillment System to Maximize the Productivity of CosmoFarm’s Pharmaceutical Logistic Center in Athens, Greece
Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices,...
Sep 21, 2021 09:15 am ET
Cosmos Holdings Secures Approximately $5.5 Million Investment from Ault Global Holdings
Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices,...
Aug 18, 2021 09:15 am ET
Cosmos Holdings Announces Voluntary Conversion of Debt to Equity by the Company’s Senior Lender, Further Enhancing the Balance Sheet
Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), an international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices, and an extensive, established European...
Aug 17, 2021 09:24 am ET
Cosmos Holdings Reports 15.8% Year-Over-Year Growth and 27.8% Sequential Increase in Revenue for the Second Quarter of 2021
Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, established European Union distribution...
Aug 10, 2021 09:15 am ET
Cosmos Holdings to Open Flagship Store on Alibaba’s Tmall Global, World’s Largest Cross-Border E-Commerce Marketplace with 500M Monthly Active Users
Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), an international pharmaceutical company with a proprietary line of branded pharmaceuticals, nutraceuticals and OTC medications, today announced that it has signed a distribution agreement for its...
Jul 26, 2021 09:25 am ET
Cosmos Holdings CEO Greg Siokas Converts an Additional $1.25 Million of Debt into Common Stock at $6.00 Per Share
Cosmos Holdings, Inc. (“the Company”) (OTCQX: COSM), an international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, established European Union distribution...
Jul 16, 2021 09:38 am ET
Cosmos Holdings CEO Greg Siokas Converts an Additional $1.0 Million of Debt into Common Stock at $6.00 Per Share
Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), an international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, established European Union distribution...
Jul 08, 2021 09:25 am ET
Cosmos Holdings Signs Exclusive Distribution Agreement with Mediprovita GbR for Launch of Sky Premium Life Products in Germany and Austria
Cosmos Holdings, Inc. (the “Company") (OTCQX: COSM), an international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, established European Union distribution...
Jul 01, 2021 09:15 am ET
Cosmos Holdings Appoints Finance Veteran Alexi Papaconstantinou to its Advisory Board
Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), an international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, established European Union distribution...
Jun 28, 2021 09:25 am ET
Cosmos Holdings CEO Greg Siokas Converts $3.0 Million of Debt into Common Stock at $6.00 Per Share
Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), an international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, established European Union distribution...
May 18, 2021 09:00 am ET
Cosmos Holdings Provides First Quarter 2021 Business Update; Reports 89% Year-Over-Year and 60% Sequential Increase in Nutraceutical Business
Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), a vertically integrated, international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, established...
Apr 27, 2021 09:15 am ET
Cosmos Holdings to Launch Sky Premium Life Nutritional Supplements on Amazon UK
Cosmos Holdings, Inc. (“the Company”) (OTCQX: COSM), a vertically integrated, international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, established...
Apr 16, 2021 09:15 am ET
Cosmos Holdings Reports Revenue Growth of 40% to a Record $55.4 Million and Achieves Profitability for 2020
Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), a vertically integrated, international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, established...
Apr 14, 2021 09:16 am ET
Cosmos Holdings Launches Proprietary King Eros and Queen Venus Supplements for Enhanced Libido
Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), a vertically integrated, international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, established EU...
Apr 08, 2021 10:05 am ET
Cosmos Holdings Launches Mosept-Oral Antiseptic Spray Designed to be Effective Against Bacteria and Certain Viral Pathogens
Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), a vertically integrated, international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, established EU...
Feb 11, 2021 09:35 pm ET
Cosmos Holdings Launches Osteodome in EU
Cosmos Holdings, Inc. (“the company") (OTCQX: COSM), a vertically integrated, international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, established EU...
Jan 11, 2021 09:30 am ET
Cosmos Holdings Launches New Proprietary Enhanced Dietary Supplement
Cosmos Holdings, Inc. (“the company") (OTCQX: COSM), a vertically integrated international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, established EU...
Dec 04, 2020 12:22 pm ET
Cosmos Holdings Announces December 4th Virtual Bell Ringing to Open Trading on the OTCQX Best Market
Cosmos Holdings, Inc. (“the company") (OTCQX: COSM), a vertically integrated international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, established EU...
Nov 25, 2020 09:45 am ET
Cosmos Holdings Begins Trading on the OTCQX® Best Market
Cosmos Holdings, Inc. (“the company") (OTCQX: COSM), a vertically integrated international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, established EU...
Nov 25, 2020 06:00 am ET
OTC Markets Group Welcomes Cosmos Holdings Inc. to OTCQX
NEW YORK, Nov. 25, 2020 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 11,000 U.S. and global securities, today announced Cosmos Holdings Inc. (OTCQX: COSM), an international pharmaceutical company, has qualified to trade on the OTCQX® Best Market. Cosmos Holdings Inc. upgraded to OTCQX from the OTCQB® Venture Market.
Nov 17, 2020 09:16 am ET
Cosmos Holdings, Inc. Reports Record Third Quarter and Nine-Month Financial Results
Cosmos Holdings, Inc. (“the company") (OTCQΒ: COSM), an international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, established EU distribution network,...
Nov 02, 2020 09:35 am ET
David Lowenstein Agrees to Join Cosmos Board of Directors
Cosmos Holdings, Inc. (“the company") (OTCQB: COSM), an international pharmaceutical wholesaler with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices and an extensive, established EU...
Oct 16, 2020 09:00 am ET
Cosmos Holdings Engages PGS Ventures to Advise on Strategic Transactions to Accelerate Core Business Expansion
Cosmos Holdings, Inc. (the “Company") (OTCQB: COSM), an international pharmaceutical company, announced today that it has entered into an advisory agreement with PGS Ventures B.V. (PGS), an Amsterdam corporation (the Advisor), to identify and...
Aug 18, 2020 01:47 pm ET
Cosmos Holdings, Inc. Announces Q2 2020 Financial and Operating Results
Cosmos Holdings, Inc. (the “Company") (OTCQB: COSM), an international pharmaceutical company, announced consolidated financial results for the first six months ended June 30, 2020, prepared in accordance to Generally Accepted Accounting Principles...
May 20, 2020 08:00 am ET
Cosmos Holdings, Inc. Announces Year End 2019 & Q1 2020 Financial and Operating Results
Cosmos Holdings, Inc. (the ‘’Company") (OTCQB: COSM), an international pharmaceutical company, announced consolidated financial results for the fiscal year ended December 31, 2019 and the quarter ended March 31, 2020, prepared in accordance to...
Apr 08, 2020 03:42 pm ET
COSMOS HOLDINGS, INC. SIGNS FOR EXCLUSIVE REPRESENTATION AGREEMENT OF COVID-19 DIAGNOSTIC DETECTION KIT FOR GERMANY, ENGLAND, GREECE & CYPRUS
Cosmos Holdings, Inc. ("the Company") (OTCQB: COSM), an international pharmaceutical company, announced today that it has signed a definitive agreement with SunMed Biosciences Limited to be the exclusive representative and distribution agent of a...
Oct 16, 2019 01:42 pm ET
Cosmos Holdings Engages Exchange Listing To Assist with its NASDAQ-Listing
Cosmos Holdings Inc. (OTCQB: COSM) (the “Company”) today announced it has engaged Exchange Listing LLC to assist with the planning and implementation of an up-listing of its common stock to the NASDAQ Capital Markets. “We plan to list our...
Jun 25, 2019 11:00 am ET
Cosmos Holdings, Inc. Completes $550,000 Debt-to-Equity Conversion at $7.50 Per Share
Cosmos Holdings, Inc. (“Cosmos” or the “Company”) (OTCQB: COSM), an international pharmaceutical company, announced today it agreed to issue 73,334 shares of common stock to Grigorios Siokas, the Company’s CEO, in exchange for the repayment of...
May 31, 2019 12:00 pm ET
Cosmos Holdings, Inc. Completes $500,000 Debt-to-Equity Conversion at $7.50 Per Share
Cosmos Holdings, Inc. (“Cosmos” or the “Company”) (OTCQB: COSM), an international pharmaceutical company, announced today it agreed to issue 66,667 shares of common stock to Grigorios Siokas, the Company’s CEO, in exchange for the repayment of...
Apr 23, 2019 12:27 pm ET
Cosmos Holdings, Inc. Announces Year End 2018 Financial Results
Cosmos Holdings, Inc. ("the Company") (OTCQB: COSM), an international pharmaceutical company, announced its full-year 2018 financial results for the year ended December 31, 2018. 2018 Highlights: Revenue improved 23.6% to $37 million from $30...
Feb 20, 2019 11:47 am ET
Cosmos Holdings, Inc. Adds to Its Advisory Board
Cosmos Holdings, Inc. ("the Company") (OTCQB: COSM), an international pharmaceutical company, announced that it has added executive Vassos Efthymiadis to its advisory board.  Mr. Efthymiadis is the Managing Director of K&N Efthymiadis S.A. and Vice...
Feb 06, 2019 09:00 am ET
Cosmos Holdings, Inc. Pays Off All Convertible Debt
Cosmos Holdings, Inc. (OTCQB: COSM), an international pharmaceutical company, announced today that it paid off the remaining balance of its convertible notes.  The aggregate initial principal amounts of the notes totaled $5,583,333. Cosmos...
Jan 11, 2019 09:00 am ET
Cosmos Holdings, Inc. Adds Distinguished Portfolio Manager With Mid-Cap & Large-Cap Value Expertise to Its Advisory Board
Cosmos Holdings, Inc. ("the Company") (OTCQB: COSM), an international pharmaceutical company, announced that it has added Tom Kolefas to its Advisory Board. Kolefas brings more than 25 years of Wall Street experience on the buyside - managing both...
Dec 21, 2018 09:00 am ET
Cosmos Holdings, Inc. Acquires Cosmofarm Ltd.
Cosmos Holdings, Inc. (OTCQB: COSM), an international pharmaceutical company, announced the closing of its acquisition of Cosmofarm Ltd (“Cosmofarm”), a privately held company located in Athens, Greece.  Founded in 1994, Cosmofarm is a fully...
Nov 28, 2018 09:00 am ET
Cosmos Holdings, Inc. Welcomes Dr. Ioannis Dedes MD to Its Advisory Board
Cosmos Holdings, Inc. ("the Company") (OTCQB: COSM), an international pharmaceutical company, announced that it has added to its advisory board - Dr. Ioannis Dedes, MD an Interventional Radiologist and Interventional Oncologist.  Dr. Dedes is a...
Nov 21, 2018 10:16 am ET
Cosmos Holdings, Inc. Adds Distinguished Member to Its Advisory Board to Fuel International Growth
Cosmos Holdings, Inc. ("the Company") (OTCQB: COSM), an international pharmaceutical company, announced that it has added a new member to its advisory board.  Mr. Anastasios Tzikas is the president of several organizations including: Thessaloniki...
Nov 14, 2018 08:00 am ET
Cosmos Holdings, Inc. Announces Q3 Fiscal Year 2018 Financial and Operating Results
Cosmos Holdings, Inc. ("the Company") (OTCQB: COSM), an international pharmaceutical company, announced consolidated financial results for the quarter ended and nine-months ended September 30, 2018. Financial Highlights Operating...
Aug 16, 2018 08:00 am ET
Cosmos Holdings, Inc. Announces Q2 Fiscal Year 2018 Financial and Operating Results
Cosmos Holdings, Inc. ("the Company") (OTCQB: COSM), an international pharmaceutical company, announced financial results for the quarter ended June 30, 2018. Financial Highlights for the three months ended June 30, 2018: Revenues were $8.8...
Jul 24, 2018 08:00 am ET
Cosmos Holdings Inc. Enters Into Share Exchange Agreement With Marathon Global Inc. and Kaneh Bosm BioTechnology Inc.
Cosmos Holdings Inc. (the “Company”) (OTCQB:COSM), an international pharmaceutical company, announced a share exchange agreement with Marathon Global Inc. and Kaneh Bosm BioTechnology Inc. (CSE:KBB) (“Kaneh Bosm”). Cosmos Holdings Inc. completed a...
Jul 02, 2018 10:17 am ET
Cosmos Holdings, Inc. Enters into Share Purchase Agreement to acquire Cosmofarm Ltd.
Cosmos Holdings, Inc. (OTCQB:COSM), an international pharmaceutical company, announced the Company signed a Share Purchase Agreement to acquire 100% of the shares of Cosmofarm Ltd (“Cosmofarm”), a privately held company located in Athens, Greece....
Jun 25, 2018 07:00 am ET
Cosmos Holdings Submits Application for NASDAQ Capital Market Up-Listing
Cosmos Holdings, Inc. ("the Company") (OTCQB:COSM), an international pharmaceutical company, has submitted its formal application to list the company's common stock on the NASDAQ Capital Market. Cosmos Holdings CEO Gregory Siokas commented, "We...
May 30, 2018 09:42 am ET
Cosmos Holdings, Inc. Announces First Quarter 2018 Results
Cosmos Holdings, Inc. ("the Company") (OTCQB:COSM), an international pharmaceutical company, announced financial results for the quarter ended March 31, 2018. Highlights: Quarter ended March 31, 2018, versus the quarter ended March 31, 2017,...
May 01, 2018 08:00 am ET
Cosmos Holdings, Inc. Releases Its New Nutraceutical Brand
Cosmos Holdings, Inc., through its wholly owned subsidiary Sky Pharm S.A., offers a first look at its Sky Life Premium® Brand of food supplements.
Apr 20, 2018 12:45 pm ET
Cosmos Holdings, Inc. Announces Year End 2017 Financial Results
Revenue Improved 347% and Gross Profit Improved 225% compared to 2016
Mar 21, 2018 09:06 am ET
Cosmos Holdings Signs Marathon Global Inc. for Exclusive Cannabis Product Distribution Throughout Europe
CHICAGO, March 21, 2018 (GLOBE NEWSWIRE) -- COSMOS HOLDINGS INC. (OTCQB:COSM) (“Company”) is pleased to announce that it has signed a definitive agreement with Marathon Global Inc. to source and procure medical cannabis products and their derivatives for...
Mar 08, 2018 09:00 am ET
OTCQX And OTCQB Companies to Present At 2018 ROTH Conference
NEW YORK, March 8, 2018 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today unveiled the list of OTCQX® Best Market and OTCQB® Venture Market presenting companies at the 30th Annual ROTH Conference, taking place March 11-14 at The Ritz Carlton in Dana Point, California. 
Mar 02, 2018 08:42 am ET
Cosmos Holdings Inc. to Participate in the 30TH Annual ROTH Conference March 11-14, 2018
CHICAGO, March 02, 2018 (GLOBE NEWSWIRE) -- Cosmos Holdings Inc. (OTCQB:COSM) (“Company”), a fully reporting Pharmaceutical Holding Company that specializes, through its subsidiaries, in the wholesale of pharmaceutical products throughout Europe, will participate in the 30th annual ROTH...
Jan 09, 2018 10:49 am ET
Cosmos Holdings, Inc. Enters the Nutraceutical Industry
Cosmos Holdings, Inc., through its wholly owned subsidiary Sky Pharm S.A., signs agreement to develop and manufacture its own line of food supplements
Nov 28, 2017 08:00 am ET
Cosmos Holdings, Inc. Announces Third Quarter 2017 Results
Cosmos Holdings, Inc. ("the Company") (OTCQB: COSMD) (OTCQB: COSM), an international pharmaceutical company, announced financial results for the quarter ended September 30, 2017.
Nov 16, 2017 02:01 pm ET
Cosmos Holdings, Inc. Announces $3 Million Securities Purchase Agreement With Two Institutional Investors
Cosmos Holdings, Inc. ("the Company") (OTCQB: COSM), an international pharmaceutical company, announced that it has entered into a $3 million securities purchase agreement with two institutional investors.
Sep 05, 2017 08:00 am ET
Cosmos Holdings Inc. Engages ROTH Capital Partners to Provide Financial Advisory Services
Cosmos Holdings Inc. (OTCQB: COSM) ("Company"), a fully reporting Pharmaceutical Holding Company that specializes, through its subsidiaries, in the wholesale of pharmaceutical products throughout Europe, announced today that it has engaged ROTH Capital Partners, LLC ("ROTH"), a leading investment banking and securities firm, to provide financial advisory services, in particular related to evaluating multiple financing options. ROTH also will focus on assisting the Company in creating and executing new strategies for maximizing shareholder value through its full scope of investment banking
Aug 15, 2017 10:19 am ET
Cosmos Holdings, Inc. Announces Second Quarter 2017 Results
Cosmos Holdings, Inc. ("the Company") (OTCQB: COSM), an international pharmaceutical company, announced financial results for the quarter ended June 30, 2017.
Jun 27, 2017 08:00 am ET
UPDATE - Cosmos Holdings Signs Letter of Intent To Acquire CC Pharma GmbH A Leading Re-importer of EU Pharmaceuticals to Germany
Cosmos Holdings, Inc. (the Company) (OTCQB: COSM), an international pharmaceutical company, announced on June 23, 2017, that it signed a new Letter of Intent (LOI) to acquire the outstanding shares of CC Pharma GmbH, a leading re-importer of EU pharmaceuticals to Germany. This press release is issued for the purpose of updating and supplementing certain information. Under the terms of the LOI, Cosmos Holdings holds the exclusive right to complete its due diligence process and complete the transaction by October 31, 2017. In connection with the non-binding LOI, the Company is required to pay a
Jun 23, 2017 03:44 pm ET
Cosmos Holdings Signs Letter of Intent To Acquire CC Pharma GmbH A Leading Re-importer of EU Pharmaceuticals to Germany
Cosmos Holdings, Inc. (the Company) (OTCQB: COSM), an international pharmaceutical company, announced today that it signed a new Letter of Intent (LOI) to acquire the outstanding shares of CC Pharma GmbH, a leading re-importer of EU pharmaceuticals to Germany. Under the terms of the LOI, Cosmos Holdings holds the exclusive right to complete its due diligence process and complete the transaction by October 31, 2017. Financial terms of the transaction were not disclosed.
May 24, 2017 11:40 am ET
CORRECTION - Cosmos Holdings, Inc. Announces first Quarter 2017 Results
In the news release, "Cosmos Holdings, Inc. Announces first Quarter 2017 Results," issued yesterday, May 23, by Cosmos Holdings (OTCQB: COSM), we are advised by the company that the subhead should read "Revenue Improved 262% and Gross Profit Improved 315% compared to the three months ended March 31, 2016." The "revenue improved" and "gross profit" percentages in the second paragraph were also updated. Complete corrected text follows.
May 23, 2017 12:28 pm ET
Cosmos Holdings, Inc. Announces first Quarter 2017 Results
Cosmos Holdings, Inc. ("the Company") (OTCQB: COSM), an international pharmaceutical company, announced financial results for the quarter ended March 31, 2017.
Apr 19, 2017 05:58 pm ET
Cosmos Holdings, Inc. Announces Full-Year 2016 Results
Cosmos Holdings, Inc. ("the Company") (OTCQB: COSM), an international pharmaceutical company, announced financial results for the year ended December 31, 2016.
Feb 14, 2017 11:06 am ET
Cosmos Holdings, Inc. Acquires Decahedron Ltd.
Cosmos Holdings, Inc. ("the Company") (OTCQB: COSM), an international pharmaceutical company, announced today that the Company acquired 100% of the shares of Decahedron Ltd, a privately held company located in Harlow, United Kingdom just north of London.
Feb 07, 2017 12:16 pm ET
Cosmos Holdings, Inc. Establishes its Advisory Board and Adds Orestes Varvitsiotes as its Initial Member
Cosmos Holdings, Inc. ("the Company") (OTCQB: COSM), an international pharmaceutical company, announced that Orestes Varvitsiotes has been appointed as the initial board member of its Advisory Board of Directors.
Jan 25, 2017 04:05 pm ET
Cosmos Holdings, Inc. signs Letter of Intent with CC Pharma GmbH
Cosmos Holdings, Inc. ("the Company") (OTCQB: COSM), an international pharmaceutical company, announced today that the Company signed a Letter of Intent (LOI) with the sole owners of CC Pharma GmbH who intend to sell all of the outstanding shares of CC Pharma GmbH to the Company. Financial terms of the transaction were not disclosed.
Jan 11, 2017 03:56 pm ET
Cosmos Holdings, Inc. Adds John J. Hoidas to Its Board of Directors
Cosmos Holdings, Inc. ("the Company") (OTCQB: COSM), an international pharmaceutical company, announced that John J. Hoidas has been appointed to the Company's board of directors, expanding the board to four members.

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.